IL17A and neoplasm: Moreover, mice bearing HCC tumors showed diminished expression of IL-17A by hepatic type 3 innate lymphoid cells (ILC3s) when they were administered with fecal microbiome from healthy mice or Lactobacillus reuteri, which further implicated delayed tumor growth.